☆ 4.6 Letter

Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) - Rationale, design and first interim analysis

INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)

Get Full Text
Add to Collection

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 145, Issue 2, Pages 282-284

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2009.09.555

Keywords

Stem cell homing; Myocardial infarction; G-CSF; DPP-IV-inhibition; Sitagliptin

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.